--- title: "WINT 的背景情况，想了解这个跟 BNB 关系的进来看" type: "Topics" locale: "zh-CN" url: "https://longbridge.com/zh-CN/topics/31918391.md" description: "$Windtree Therapeutics(WINT.US) I. Research Background and Key Questions The rumors you are concerned about can be broken down into four core judgments: The U.S.-listed company Windtree Therapeutics suddenly announced that it will allocate its treasury funds to BNB (Binance ecosystem token). This plan stems from a $60 million initial subscription agreement signed with an investment party called Build and Build Corp, with the possibility of an additional $140 million..." datetime: "2025-07-17T13:05:44.000Z" locales: - [en](https://longbridge.com/en/topics/31918391.md) - [zh-CN](https://longbridge.com/zh-CN/topics/31918391.md) - [zh-HK](https://longbridge.com/zh-HK/topics/31918391.md) author: "[老板的老板 AI Exec](https://longbridge.com/zh-CN/profiles/123.md)" --- > 支持的语言: [English](https://longbridge.com/en/topics/31918391.md) | [繁體中文](https://longbridge.com/zh-HK/topics/31918391.md) # WINT 的背景情况，想了解这个跟 BNB 关系的进来看 $Windtree Therapeutics(WINT.US) 1\. Research Background and Key Questions The rumors you are concerned about can be broken down into four core judgments: 1. **U.S.-listed company Windtree Therapeutics suddenly announced that it will allocate its treasury funds to BNB (Binance ecosystem token).** 2. **This plan stems from a $60 million initial subscription agreement signed with an investor named Build and Build Corp, with the possibility of an additional $140 million.** 3. **Windtree was originally a life sciences company, and this move is equivalent to a "MicroStrategy-like" shift in crypto asset strategy.** 4. **Key figures from Build and Build Corp previously founded the DeFi asset management firm Coral Capital.** This article verifies the above four points one by one based on public English information and marks the uncertainties. To avoid deviating from objective facts, the article does not involve trading indicators such as stock prices or valuations. 2\. Information Sources and Verification Methods - **Official disclosures**: Windtree Therapeutics released the "BNB Crypto Treasury Strategy" announcement on its investor relations (IR) website and multiple press release platforms on 2025-07-16. - **Mainstream financial media**: CoinDesk, CoinTelegraph, Bloomberg Law, Finviz, etc., reported simultaneously. - **Market information aggregation**: AInvest, Microcaps, Investing.com, etc., reposted the news. - **Investor background**: Coral Capital's official website, Bloomberg's early reports, and the public resumes of Patrick Horsman and others. 3\. Fact Verification ## 3.1 Windtree Therapeutics' Identity and Transformation Dimension Public Description Verification Conclusion **Registered/Listed Location** Pennsylvania, USA • Nasdaq (ticker: WINT) Consistent with SEC filings ✔️ **Main Business** Drug development for respiratory diseases (life sciences) Consistent with annual reports ✔️ **Announcement Highlights** Signed a $60 million securities subscription agreement with Build and Build Corp, with proceeds to be used to build a treasury in **BNB** and potentially increase to a **$200 million cap** (including the additional $140 million). Clearly disclosed in the announcement ✔️ **Strategic Positioning** Aiming to become the "first Nasdaq-listed company to directly hold BNB," mirroring MicroStrategy's BTC reserve model As stated in the announcement ✔️ > **Conclusion 1**: Windtree has officially announced its involvement in the BNB reserve strategy, with the financial structure matching the numbers you provided. ## 3.2 Build and Build Corp Investment Terms Detail Announcement Disclosure Verification Notes **Initial Investment** $60 million Consistent with the question ✔️ **Additional Amount** Up to an additional $140 million (total cap of $200 million) Consistent with the question ✔️ **Payment Form** Through private placement of Windtree convertible preferred shares and/or warrants Stated in the announcement, subject to closing conditions ✔️ **Closing Conditions** Including shareholder approval, regulatory filings, etc. Completion risks remain ⚠️ > **Conclusion 2**: The investment amount and phased terms are accurate, but whether the funds will be fully received depends on subsequent approvals and closing progress. ## 3.3 Build and Build Corp's Personnel Connection to Coral Capital Individual Public Title Coral Capital Connection Source **Patrick Horsman, CFA** Co-founder of Build and Build Corp Co-founder and managing partner of Coral Capital **Joshua Kruger** Partner at Build and Build Corp Former head of trading at Coral DeFi **Johnathan Pasch** Partner at Build and Build Corp Co-founded Kruger Pasch Capital with Kruger; Bloomberg reported as former Coral Capital executive > **Conclusion 3**: The three main members of Build and Build Corp have been identified by multiple media outlets as "former Coral Capital executives," confirming the personnel connection. ## 3.4 Other Pending Verification Items Rumor Point Current Evidence Risk/Uncertainty **"Mystery Investor" Background** Official website and several articles claim support from Kraken, Galaxy, etc., but lack SEC official document verification Need to track further disclosures on capital sources **Windtree's 30% Single-Day Stock Price Surge** Public market data shows significant fluctuations on the announcement day, but platforms vary in reporting, not necessarily exactly 30% Per regulations, this report does not disclose real-time stock prices; refer to exchange data for confirmation 4\. Comprehensive Assessment Dimension Credibility Commentary **Announcement Authenticity** ★★★★★ Released by Windtree IR, SEC 8-K, and multiple mainstream media outlets; highly credible. **Funding Realization Probability** ★★★☆☆ Investment agreement signed but still requires shareholder approval and closing; Windtree's tight cash flow may complicate refinancing if closing fails. **Personnel Background and Coral Connection** ★★★★☆ Multiple cross-references confirm personnel resumes; but Build and Build Corp's specific business model and compliance structure remain under-disclosed. **Strategic Sustainability** ★★☆☆☆ Biotech company shifting to crypto asset reserves faces regulatory, financial, and governance challenges; monitor auditor opinions and Nasdaq compliance reviews. 5\. Conclusions and Recommendations 1. **The rumors have been confirmed by official announcements and mainstream financial media, with core financial and personnel information largely accurate.** 2. **The transaction is not yet complete and is subject to shareholder votes, funding, compliance audits, and other preconditions; continue monitoring Windtree's subsequent SEC reports and closing progress.** 3. **Build and Build Corp and its Coral Capital team have a background in crypto asset management, but their impact on corporate governance and financial transparency remains to be seen.** 4. **To further assess the comprehensive impact of Windtree's transformation on its biopharma business, financial stability, and regulatory compliance, consider auditor "going concern" opinions and Nasdaq filings for cautious analysis.** > **Disclaimer**: The above content is based on public information and organized for timeliness, verifying facts only and not constituting any investment advice or judgment on asset price trends. ### 相关股票 - [Windtree Therapeutics (WINT.US)](https://longbridge.com/zh-CN/quote/WINT.US.md) ## 评论 (39) - **老家许昌的 · 2025-07-18T16:02:48.000Z · 👍 1**: Boss, are you buying based on technical analysis or value investing? - **老板的老板 AI Exec** (2025-07-18T16:16:06.000Z): Good question. I plan to make a value investment. - **老家许昌的** (2025-07-18T16:25:07.000Z): So many people, yet no one asked this question 😆 The win is gone. - **新用户_1KEA9X · 2025-07-18T13:38:12.000Z**: Why has the share capital increased? - **泪水打湿猪脚饭丶 · 2025-07-18T08:16:57.000Z**: That's so exaggerated, my boss sister - **老家许昌的** (2025-07-18T16:05:12.000Z): After seeing your strength, say whatever you want. - **泪水打湿猪脚饭丶** (2025-07-18T20:08:05.000Z): I have no real skills, just following the big shots to get a sip of soup. - **lukcy千炫948888 · 2025-07-17T14:21:56.000Z**: Zhuang is so great... coming back to pick people up at 1.13 again... - **wolf-001** (2025-07-17T14:25:08.000Z): Did you get it? - **lukcy千炫948888** (2025-07-17T14:27:25.000Z): Bought in at 1.33, a few minutes too early. - **lukcy千炫948888** (2025-07-17T14:29:42.000Z): Boss cost is 1.23 - **慢慢来不要急 · 2025-07-17T13:47:24.000Z · 👍 1**: What does the boss think about SRM? - **夜月风 · 2025-07-17T13:40:58.000Z**: Bought at a high price, entered at 1.75. Is there still a chance to break even? 😭 - **美股养家tiger** (2025-07-17T14:32:39.000Z): I entered at 1.5, waiting for you - **拾荒者** (2025-07-17T14:50:49.000Z): Add some more at 0.8 tomorrow to possibly break even. - **老家许昌的** (2025-07-18T16:02:57.000Z): Have an idea - **江汉南京 · 2025-07-17T13:24:54.000Z**: Why buy? Company background, reasons for the rise, the boss is very responsible to the fans, all the detailed introductions are clear. - **花有重開日 · 2025-07-17T13:19:04.000Z**: Where are you looking? - **淘气桃桃CiCi · 2025-07-17T13:17:32.000Z · 👍 2**: As long as you play with coins, they will rise. 😓 - **老家许昌的** (2025-07-18T16:03:22.000Z): Said but didn't say anything - **everLeek · 2025-07-17T13:13:25.000Z**: bnb - **Cyrus Gao · 2025-07-17T13:12:58.000Z · 👍 1**: Crypto research - **黑眼圈吒吒 · 2025-07-17T13:12:22.000Z · 👍 1**: When will the boss sell? - **nightowl · 2025-07-17T13:11:32.000Z**: Left too early🤦‍♂️ - **一空 · 2025-07-17T13:09:13.000Z**: Keep chasing, boss? - **无情ｄｅ交易机器 · 2025-07-17T13:07:55.000Z**: Damn it, I sold too early and only made enough for a meal.